Effects of GLP-1 agonists on proportion of weight loss in obesity with or without diabetes: Systematic review and meta-analysis
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Public Health, Environmental and Occupational Health,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference84 articles.
1. Effects of exenatide combined with lifestyle modification in patients with type 2 diabetes;Apovian;Am. J. Med.,2010
2. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study;Armstrong;Lancet,2016
3. Pioneer 1: randomized clinical trial of the efficacy and safety of oral semaglutide monotherapy in comparison with placebo in patients with type 2 diabetes;Aroda;Diabetes Care,2019
4. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study;Astrup;Lancet,2009
5. Efficacy and safety of lixisenatide once daily vs. placebo in people with Type 2 diabetes insufficiently controlled on metformin (GetGoal-F1);Bolli;Diabet. Med.,2014
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Transformative weight loss with Dulaglutide: A case report of success in a challenging patient profile of an ex‐sumo wrestler;Clinical Case Reports;2024-08-29
2. The Antiobesity Effect and Safety of GLP-1 Receptor Agonist in Overweight/Obese Adolescents Without Diabetes Mellitus: A Systematic Review and Meta-Analysis;Cureus;2024-08-06
3. Weight regain after intragastric balloon for pre-surgical weight loss;World Journal of Gastrointestinal Surgery;2024-07-27
4. An Assessment of Semaglutide Safety Based on Real World Data: From Popularity to Spontaneous Reporting in EudraVigilance Database;Biomedicines;2024-05-18
5. Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks;Alimentary Pharmacology & Therapeutics;2024-01-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3